Document Detail


Paternal Exposure to Methotrexate and Pregnancy Outcomes.
MedLine Citation:
PMID:  21239747     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVE: To assess the risk of major malformation in the case of paternal exposure to methotrexate (MTX) at the time of conception. METHODS: Using prospective data of our Teratology Information Service, we analyzed outcomes of paternal MTX exposure at the time of conception or up to 3 months before conception. RESULTS: We report on the outcomes of 42 pregnancies involving 40 men treated with MTX at the time of conception. Twenty-three men were treated for an inflammatory disease (54.8%), 9 for psoriasis (21.4%), and 8 for a malignant disease (19.0%). Weekly dosages varied between 7.5 mg and 30 mg. The pregnancies resulted in 36 live births, 3 spontaneous abortions, and 3 voluntary abortions. No congenital malformation was observed at birth. CONCLUSION: Based on our results and case reports in literature, paternal MTX exposure at the time of conception does not seem to raise any major concern for offspring.
Authors:
Delphine Beghin; Marie-Pierre Cournot; Catherine Vauzelle; Elisabeth Elefant
Related Documents :
10999657 - The influence of birth weight, rate of weight gain and final achieved height and sex on...
9598947 - Nutritional stress of reproduction. a cohort study over two consecutive pregnancies.
11784897 - Assessment of weight gain during pregnancy in general prenatal care services in brazil.
7233287 - Maternal nutrition and the duration of pregnancy.
2368867 - Maintenance of nonsmoking postpartum by women who stopped smoking during pregnancy.
9466187 - Intrauterine insemination for treatment of male infertility.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-1-15
Journal Detail:
Title:  The Journal of rheumatology     Volume:  -     ISSN:  0315-162X     ISO Abbreviation:  -     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-1-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7501984     Medline TA:  J Rheumatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
From the Centre de Référence sur les Agents Tératogènes (CRAT), Hôpital Armand Trousseau, Groupe Universitaire Est, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Validation of the Functional Assessment of Chronic Illness Therapy-Fatigue Scale in Patients with Mo...
Next Document:  Comparison of certolizumab pegol with other anticytokine agents for treatment of rheumatoid arthriti...